Coming soon to a clinic near you? The antibody infusion pipeline
27 January 2021
•
RT01
•
16:15
>
17:15
•
Coming soon to a clinic near you? The antibody infusion pipeline
•
Live channel 2
This session reviews ongoing and planned clinical development activities for the various major research initiatives advancing passive administration of bNAbs for prevention. Speakers will review their respective program strategies, target product profiles, timelines for candidates in development and ongoing research into next-generation optimized bNAb candidates. This session also looks at the potential role of bNAbs as part of the broader HIV prevention landscape, including vaccines and long-acting ARVs, and the evolving complexities of clinical efficacy trial design.
16:15
•
RT01.01
•
Optimization of bNAbs for HIV prevention
See abstract
16:23
•
RT01.02
•
Engineered bispecific bNAbs
See abstract
16:31
•
RT01.03
•
Preclinical to clinical: 3BNC117 and 10-1074 bNAb combination for HIV prophylaxis
See abstract
16:39
•
RT01.04
•
Passive bNAb infusion pipeline
See abstract
16:47
•
RT01.05
•
Antibodies against COVID-19
See abstract
16:55
•
RT01.06
•
Panel discussion
See abstract
|